Park SB, Goldstein D, Krishnan AV et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63(6):419–437
Chan CW, Cheng H, Au SK et al (2018) Living with chemotherapy-induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors. Eur J Oncol Nurs 36:135–141
Staff NP, Grisold A, Grisold W et al (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781
Article CAS PubMed PubMed Central Google Scholar
Monfort SM, Pan X, Patrick R et al (2017) Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat 164(1):69–77
Article CAS PubMed PubMed Central Google Scholar
Hertz DL (2024) Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy. Curr Opin Support Palliat Care 18(1):30–38. https://doi.org/10.1097/SPC.0000000000000684
Loprinzi CL, Lacchetti C, Bleeker J et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: asco guideline update. J Clin Oncol 38(28):3325–3348
Jordan B, Margulies A, Cardoso F et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol 31(10):1306–1319
Article CAS PubMed Google Scholar
Hertz DL, Tofthagen C, Rossi E et al (2023) Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. Support Care Cancer 32(1):48. https://doi.org/10.1007/s00520-00023-08209-00520
Tsuyuki S, Senda N, Kanng Y et al (2016) Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group. Breast Cancer Res Treat 160(1):61–67. https://doi.org/10.1007/s10549-10016-13977-10547
Article CAS PubMed Google Scholar
Kanbayashi Y, Sakaguchi K, Ishikawa T et al (2020) Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial. Breast 49:219–224. https://doi.org/10.1016/j.breast.2019.1012.1011
Sundar R, Bandla A, Tan SS et al (2016) Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: a pilot study. Front Oncol 6:274. https://doi.org/10.3389/fonc.2016.00274.eCollection02016
Ruddy KJ, Le-Rademacher J, Lacouture ME et al (2019) Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. Breast 48:89–97. https://doi.org/10.1016/j.breast.2019.1009.1011
Beijers AJM, Bonhof CS, Mols F et al (2020) Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy. Ann Oncol 31(1):131–136. https://doi.org/10.1016/j.annonc.2019.1009.1006
Article CAS PubMed Google Scholar
Streckmann F, Elter T, Lehmann HC, Baurecht H, Nazarenus T, Oschwald V, Koliamitra C, Otten S, Draube A, Heinen P, Steinmetz T, Hallek M, Leitzmann M, Bloch W, Balke M (2024) Preventive effect of neuromuscular training on chemotherapy-induced neuropathy: A randomized clinical trial JAMA. Intern Med 184:1046–1053. https://doi.org/10.1001/jamainternmed.2024.2354
Park SB, Tamburin S, Schenone A et al (2022) Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion. Expert Rev Neurother 22(1):65–76. https://doi.org/10.1080/14737175.14732022.12018300
Article CAS PubMed PubMed Central Google Scholar
Sturgeon KM, Kok DE, Kleckner IR et al (2023) Updated systematic review of the effects of exercise on understudied health outcomes in cancer survivors. Cancer Med 12(24):22278–22292. https://doi.org/10.21002/cam22274.26753
de Boer AG, Tamminga SJ, Boschman JS et al (2024) Non-medical interventions to enhance return to work for people with cancer. Cochrane Database Syst Rev 3(3):CD007569. https://doi.org/10.1002/14651858.CD14007569.pub14651854
Turner RR, Steed L, Quirk H et al (2018) Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst Rev 9(9):CD010192. doi: 010110.011002/14651858.CD14010192.pub14651853
Coletta AM, Basen-Engquist KM, Schmitz KH (2022) Exercise across the cancer care continuum: why it matters, how to implement it, and motivating patients to move. Am Soc Clin Oncol Educ Book 42:1–7. https://doi.org/10.1200/EDBK_349635
Schloss JM, Colosimo M, Airey C et al (2017) A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer 25(1):195–204
Loprinzi CL, Qin R, Dakhil SR et al (2014) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol 32(10):997–1005
Article CAS PubMed Google Scholar
Hershman DL, Unger JM, Crew KD et al (2013) Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol 31(20):2627–2633
Article CAS PubMed PubMed Central Google Scholar
Ambrosone CB, Zirpoli GR, Hutson AD et al (2020) Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol 38(8):804–814. doi: 10.1200/JCO.1219.01203
Shakeel F, Fang F, Kidwell KM et al (2020) Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents. J Oncol Pharm Pract 26(8):1843–1849. https://doi.org/10.1177/1078155220905009
Chang TW, Yang FY, Liu YC et al (2024) Gabapentinoids for chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis. BMJ Support Palliat Care 27(004362):2023–004362
Kanzawa-Lee G, Krauss JC, Knoerl R (2024) Exploring chemotherapy-induced peripheral neuropathy management practice patterns among oncology clinicians. Semin Oncol Nurs 26(151685):151685
Smith EM, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309(13):1359–1367
Article PubMed PubMed Central Google Scholar
Dorsey SG, Kleckner IR, Barton D et al (2019) The national cancer institute clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J Natl Cancer Inst 111(6):531–537. doi: 510.1093/jnci/djz1011
Knoerl R, Berry D, Meyerhardt JA et al (2022) Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis. Support Care Cancer 30(12):9963–9973. doi: 9910.1007/s00520-00022-07447-y
Salgado TM, Quinn CS, Krumbach EK et al (2020) Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study. Support Care Cancer 28(9):4163–4172. https://doi.org/10.1007/s00520-00019-05254-00526
Article PubMed PubMed Central Google Scholar
Salgado TM, Liu J, Reed HL et al (2020) Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: a pilot study. Breast 51:21–28. https://doi.org/10.1016/j.breast.2020.1002.1011
Article PubMed PubMed Central Google Scholar
Suarez-Lledo V, Alvarez-Galvez J (2021) Prevalence of health misinformation on social media: systematic review. J Med Internet Res 23(1):e17187. doi: 17110.12196/17187
Arem H, Duan X, Ehlers DK et al (2021) Provider discussion about lifestyle by cancer history: a nationally representative survey. Cancer Epidemiol Biomarkers Prev 30(2):278–285. https://doi.org/10.1158/1055-9965.EPI-1120-1268
Panesar P, Mayo SJ (2023) “Taking out the trash”: strategies for preventing and managing fraudulent data in web-surveys. Can Oncol Nurs J 33(2):283–284 (eCollection 2023 Spring)
留言 (0)